miR-200-b overexpression

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

miR-200-b overexpression	Non Small Cell Lung Cancer	miR-200-b overexpression	Non Small Cell Lung Cancer	pembrolizumab Sensitive: C3 – Early Trials pembrolizumab Sensitive : C3	pembrolizumab Sensitive: C3 – Early Trials pembrolizumab Sensitive : C3
miR-200-b overexpression	Non Small Cell Lung Cancer	miR-200-b overexpression	Non Small Cell Lung Cancer	nivolumab Sensitive: C3 – Early Trials nivolumab Sensitive : C3	nivolumab Sensitive: C3 – Early Trials nivolumab Sensitive : C3

Associations